Hany Elbeshbeshy, Neal Modi, Twinkle Patel, Ian Matthews, Timothy Kampert, Jaenic Lee, Raymond Okeke, Yasar Caliskan, Vidyaratna Fleetwood, Chintalapati Varma, Brittney Gabris, Bahar Bastani, Fadee Abu Al Rub, Alexis Guenette, Alex Befeler, Uchenna Agbim, Roshani Desai, Eyad Alsabbagh, Kamran Qureshi, Mark Schnitzler, Krista L Lentine, Henry B Randall, Mustafa Nazzal
BACKGROUND: With the introduction of direct-acting antiviral therapies (DAAs), the non-use rate of hepatitis C virus (HCV)-positive donor organs (D+) has decreased significantly. We present the donor, recipient, and transplant allograft characteristics, along with recipient outcomes, in one of the largest cohorts of HCV-D+ transplants into HCV-naïve recipients (R-). METHODS: Charts of HCV D+/R- kidney (KT), liver (LT), and simultaneous liver-kidney (SLKT) transplant recipients between January 2019 and July 2022 were reviewed...
October 16, 2023: Clinical Transplantation